1-1 of 1
Yali Zhu, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of Lonafarnib (SCH66336) in Combination with Imatinib for Patients (Pts) with Chronic Myeloid Leukemia (CML) after Failure to Imatinib.

Jorge Cortes, M.D., Susan O’Brien, M.D., Srdan Verstovsek, M.D., George Daley, M.D., Charles Koller, M.D., Alessandra Ferrajoli, M.D., Odeal Pate, R.N., Stefan Faderl, M.D., Farhad Ravandi-Kashani, M.D., Moshe Talpaz, M.D., Yali Zhu, Ph.D., Paul Statkevich, Ph.D., Mary Sugrue, M.D., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2004) 104 (11): 1009.
https://doi.org/10.1182/blood.V104.11.1009.1009
Published: 2004